Bryant David Lim - Net Worth and Insider Trading
Bryant David Lim Net Worth
The estimated net worth of Bryant David Lim is at least $39,040 dollars as of 2024-12-26. Bryant David Lim is the CLO, Interim CFO, Corp Sec. of Prelude Therapeutics Inc and owns about 27,400 shares of Prelude Therapeutics Inc (PRLD) stock worth over $38,360. Bryant David Lim is also the SVP AND GENERAL COUNSEL of Aceragen Inc and owns about 1,790 shares of Aceragen Inc (ACGN) stock worth over $680. Details can be seen in Bryant David Lim's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bryant David Lim has not made any transactions after 2024-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bryant David Lim
Bryant David Lim Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bryant David Lim owns 2 companies in total, including Aceragen Inc (ACGN) , and Prelude Therapeutics Inc (PRLD) .
Click here to see the complete history of Bryant David Lim’s form 4 insider trades.
Insider Ownership Summary of Bryant David Lim
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACGN | Aceragen Inc | 2021-03-25 | SVP & General Counsel |
| PRLD | Prelude Therapeutics Inc | 2024-12-19 | Chief Legal Counsel & Corp Sec. |
Bryant David Lim Latest Holdings Summary
Bryant David Lim currently owns a total of 2 stocks. Among these stocks, Bryant David Lim owns 27,400 shares of Prelude Therapeutics Inc (PRLD) as of December 19, 2024, with a value of $38,360 and a weighting of 98.26%. Bryant David Lim also owns 1,790 shares of Aceragen Inc (ACGN) as of March 25, 2021, with a value of $680 and a weighting of 1.74%.
Latest Holdings of Bryant David Lim
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2024-12-19 | 27,400 | 1.40 | 38,360 |
| ACGN | Aceragen Inc | 2021-03-25 | 1,790 | 0.38 | 680 |
Holding Weightings of Bryant David Lim
Bryant David Lim Form 4 Trading Tracker
According to the SEC Form 4 filings, Bryant David Lim has made a total of 2 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Prelude Therapeutics Inc is the acquisition of 25,000 shares on December 19, 2024, which cost Bryant David Lim around $22,750.
According to the SEC Form 4 filings, Bryant David Lim has made a total of 5 transactions in Aceragen Inc (ACGN) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Aceragen Inc is the sale of 449 shares on March 25, 2021, which brought Bryant David Lim around $10,377.
Insider Trading History of Bryant David Lim
- 1
Bryant David Lim Trading Performance
GuruFocus tracks the stock performance after each of Bryant David Lim's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryant David Lim is -14.47%. GuruFocus also compares Bryant David Lim's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryant David Lim within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bryant David Lim's insider trading performs compared to the benchmark.
Performance of Bryant David Lim
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.8 | | | | | |
| Relative Return to S&P 500(%) | -12.88 | | | | | |
Bryant David Lim Ownership Network
Bryant David Lim Owned Company Details
What does Aceragen Inc do?
Who are the key executives at Aceragen Inc?
Bryant David Lim is the SVP & General Counsel of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .
Aceragen Inc (ACGN) Insider Trades Summary
Over the past 18 months, Bryant David Lim made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 5,818 shares made by Pillar Invest Corp , a net sale of 3,283 shares made by Vincent Milano , and a net sale of 51 shares made by Maxine Gowen .
In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,152 shares of Aceragen Inc (ACGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,152 shares.
Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aceragen Inc Insider Transactions
Bryant David Lim Mailing Address
Above is the net worth, insider trading, and ownership report for Bryant David Lim. You might contact Bryant David Lim via mailing address: C/o Idera Pharmaceuticals, Inc., 505 Eagleview Blvd., Suite 212, Exton Pa 19341.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
